The IQOS Investment Thesis Is Still Robust Philip Morris International (NYSE:PM) has reported a mixed report card for FQ1’23, in our opinion. It reported...
uniQure N.V. (NASDAQ:QURE), a trailblazing gene therapy firm, stands out as a compelling investment opportunity poised to redefine the treatment landscape for various challenging...